STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

VNRX VOLITIONRX LIMITED StockScouter® Report

4

StockScouter® Score

VOLITIONRX LIMITED, a micro cap company in the healthcare sector, is expected to underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
  • Shares are neither being accumulated heavily nor sold heavily by financial institutions. Neutral for a small company like VNRX

 

Concerns

  • The enterprise value-to-sales ratio is much higher than the average for comparably-sized companies in the StockScouter universe. Very Negative
  • The most recent quarterly earnings report was slightly lower than analysts’ consensus forecast. Neutral/Negative

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, stocks will be , and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 20% done.
Low
High

Core Model Grades

C
C
F
D

Previous Ratings

4
6
6